TORONTO: Northern Lights has completed the first direct response television (DRTV) campaign for RESPeRATE - the only FDA-cleared, non-drug medical device clinically proven to lower high blood pressure.
Consisting of a 120- and 60-second commercial, the DRTV campaign uses product demonstration, as well as testimonials from both customers and a medical expert, to highlight the medical benefits of using RESPeRATE.
"Over 50 million Americans suffer from high blood pressure. RESPeRATE can significantly lower it, is a new non-drug treatment that has no side effects, and is available without a prescription," says Tim Maroney, Vice President of Marketing for InterCure, which manufactures the product. "We awarded the DRTV project to Northern Lights because they understand the importance of both selling and brand reinforcement."
Ian French, President and Executive Creative Director of Northern Lights, believes that RESPeRATE and DRTV are a perfect fit. "We expect a product like RESPeRATE to do very well in DRTV. Not only is it effective and easy to use, but it is approved by the FDA and widely accepted by the medical community."
The campaign is set to begin with a test flight of media in early February.
Northern Lights Direct Response Television is a leading brand-based DRTV agency in North America, providing strategy, media, creative and production services. Clients include ING DIRECT, Columbia House, Sports Illustrated, Bell, Manulife Financial, TD Bank Financial Group, DIRECTV, Scholastic Inc. and Yves Rocher.
InterCure, headquartered in Fort Lee, New Jersey, is a medical device company that has developed and patented the RESPeRATE technology.
-30-
For further information:
Mr. Ian French, President and Executive Creative Director, Northern Lights Direct Response Television.
Phone: (416) 593-6104 x 223. Email:
ian@nldrtv.com. Website:
www.nldrtv.com.
